BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26559995)

  • 1. Does long-term survival exist in pancreatic adenocarcinoma?
    Zijlstra M; Bernards N; de Hingh IH; van de Wouw AJ; Goey SH; Jacobs EM; Lemmens VE; Creemers GJ
    Acta Oncol; 2016; 55(3):259-64. PubMed ID: 26559995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
    Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
    World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma.
    Chen KT; Devarajan K; Hoffman JP
    Ann Surg Oncol; 2015 Apr; 22(4):1185-9. PubMed ID: 25384699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands.
    van der Geest LG; Besselink MG; van Gestel YR; Busch OR; de Hingh IH; de Jong KP; Molenaar IQ; Lemmens VE
    Acta Oncol; 2016; 55(3):278-85. PubMed ID: 26552841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
    Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
    Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does preoperative biliary drainage compromise the long-term survival of patients with pancreatic head carcinoma?
    Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Sasaki H; Hatano N; Kohmo T; Sueda T
    J Surg Oncol; 2015 Mar; 111(3):270-6. PubMed ID: 25266938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
    Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
    Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
    Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma.
    Lee SR; Kim HO; Son BH; Yoo CH; Shin JH
    Hepatogastroenterology; 2013; 60(122):358-62. PubMed ID: 23574658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Preoperative Biliary Drainage on Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma: A Multicenter Observational Study.
    Uemura K; Murakami Y; Satoi S; Sho M; Motoi F; Kawai M; Matsumoto I; Honda G; Kurata M; Yanagimoto H; Nishiwada S; Fukumoto T; Unno M; Yamaue H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1238-46. PubMed ID: 26014151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer.
    Kurahara H; Takao S; Kuwahata T; Nagai T; Ding Q; Maeda K; Shinchi H; Mataki Y; Maemura K; Matsuyama T; Natsugoe S
    Ann Surg Oncol; 2012 Jul; 19(7):2264-71. PubMed ID: 22350599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.
    Winter JM; Brennan MF; Tang LH; D'Angelica MI; Dematteo RP; Fong Y; Klimstra DS; Jarnagin WR; Allen PJ
    Ann Surg Oncol; 2012 Jan; 19(1):169-75. PubMed ID: 21761104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.